🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary Objective: To demonstrate equivalence in exposure to insulin glarg...
Status
Completed
Location
Investigational Site Number 276001
Start Date
2013-04
Trial ID
NCT01838083
Treatments Being Tested
To investigate the mutual interaction potential of digoxin, furosemide, met...
Status
Completed
Location
352.2082.1 Boehringer Ingelheim Investigational Site
Start Date
2014-09-01
Trial ID
NCT02231931
Comparative, Randomized, Single Dose, Two-way Crossover Bioequivalence Stud...
Status
Completed
Location
Genuine Research Center GRC
Start Date
2022-11-29
Trial ID
NCT05798715
Treatments Being Tested
This four-period, single-center, open-label, single-dose, randomized, cross...
Status
Completed
Location
Multiple Locations
Start Date
2012-09
Trial ID
NCT01697436
Treatments Being Tested
The SUBMO-PIC01-2025 study evaluates whether SUBMO®, a submucosal injection...
Status
Recruiting
Location
Hospital Universitario de la Santa Creu i Sant Pau
Start Date
2026-04-29
Trial ID
NCT07448129
Treatments Being Tested
This is a single dose, open-label, randomised, two period, two-way cross-ov...
Status
Completed
Location
CROSS Research S.A., Phase I Unit,
Start Date
2018-07-23
Trial ID
NCT04678076
Treatments Being Tested
The primary objective of the current study is to demonstrate the equivalent...
Status
Completed
Location
The Oncology Institute of Hope and Innovation
Start Date
2019-05-15
Trial ID
NCT03976102
Treatments Being Tested
Through the method of a clinical randomized controlled trial, patients meet...
Status
Unknown
Location
Union Hospital Tongji Medical College Huazhong University of Science and Technology
Start Date
2024-02-01
Trial ID
NCT06154707
Treatments Being Tested
Primary Objective: To demonstrate: * the non-inferiority of the seroprote...
Status
Completed
Location
Investigational Site Number 2080001
Start Date
2019-09-12
Trial ID
NCT03890367
The objective of this study protocol is to determine the efficacy of using ...
Status
Completed
Location
Barkley Memorial Center
Start Date
2019-04-02
Trial ID
NCT03850678
Treatments Being Tested